Experienced in Ebola Virus Disease

Dr. Herbert L. Dupont

Infectious Disease
6720 Bertner St # 1-164, 
Houston, TX 
Experienced in Ebola Virus Disease
6720 Bertner St # 1-164, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Herbert Dupont is an Infectious Disease provider in Houston, Texas. Dr. Dupont is rated as an Experienced provider by MediFind in the treatment of Ebola Virus Disease. His top areas of expertise are Compartment Syndrome, Viral Gastroenteritis, Liver Failure, Sepsis, and Endoscopy.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Ebola Virus Disease.

Specialties
Infectious Disease
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

6720 Bertner St # 1-164, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea
Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Twice Weekly Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally for 12 Weeks in Subjects With Parkinson's Disease
A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Twice Weekly Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally for 12 Weeks in Subjects With Parkinson's Disease
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: PRIM-DJ2727 Filtered Fecal Microbiota
Study Phase: Phase 1
Phase II. Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
Phase II. Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
Enrollment Status: Terminated
Publish Date: March 06, 2020
Intervention Type: Biological
Study Phase: Phase 2
A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route
A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route
Enrollment Status: Completed
Publish Date: March 25, 2019
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Prospective, Randomized Placebo Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Weekly Administration of Lyophilized PRIM-DJ2727 Given Orally in Subjects With Parkinson's Disease
A Prospective, Randomized Placebo Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Weekly Administration of Lyophilized PRIM-DJ2727 Given Orally in Subjects With Parkinson's Disease
Enrollment Status: Withdrawn
Publish Date: August 10, 2018
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Enrollment Status: Completed
Publish Date: December 15, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

134 Total Publications

Microbiome Alterations During and After International Travel.
Microbiome Alterations During and After International Travel.
Journal: Journal of travel medicine
Published: July 11, 2025
Similar Doctors
Advanced in Ebola Virus Disease
Dr. Susan F. Mclellan
Infectious Disease
Advanced in Ebola Virus Disease
Dr. Susan F. Mclellan
Infectious Disease

Utmb Faculty Group Practice

301 University Blvd, 
Galveston, TX 
 (46.5 miles away)
409-772-2222
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Susan Mclellan is an Infectious Disease provider in Galveston, Texas. Dr. Mclellan is rated as an Experienced provider by MediFind in the treatment of Ebola Virus Disease. Her top areas of expertise are Ebola Virus Disease, Strep Throat, Myelitis, and Cryptococcosis. Dr. Mclellan is currently accepting new patients.

Robert L. Atmar
Experienced in Ebola Virus Disease
Dr. Robert L. Atmar
Infectious Disease
Experienced in Ebola Virus Disease
Dr. Robert L. Atmar
Infectious Disease

Baylor College Of Medicine

1504 Taub Loop, 
Houston, TX 
 (0.4 miles away)
713-873-2000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Robert Atmar is an Infectious Disease provider in Houston, Texas. Dr. Atmar is rated as an Advanced provider by MediFind in the treatment of Ebola Virus Disease. His top areas of expertise are Flu, Viral Gastroenteritis, Avian Influenza, and Asymptomatic Bacteriuria. Dr. Atmar is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dupont's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile